Nhau

Nyika haigone kuisa vakwegura panjodzi nekurerutsa mutemo weCOVID

NaZHANG ZHIHAO | CHINA DAILY | Yakagadziridzwa: 2022-05-16 07:39

Mumwe mugari wekare anoongororwa BP yake asati apihwa jekiseni rake rekutiMushonga unobetsera kudzivirira covid-19kumba mudunhu reDongcheng muBeijing, Chivabvu 10, 2022. [Mufananidzo/Xinhua]

Nyanzvi yezvirwere zvinotapukira yakati, kubatsirwa kwevakwegura nejekiseni rekuwedzera, kutarisira varwere vatsva nezviwanikwa zvekurapa zviri nani, kuongororwa kuri nyore uye kuri nyore, uye kurapwa kweCOVID-19 kumba ndezvimwe zvezvinhu zvakakosha kuti China igadzirise mutemo wayo wekare wekudzivirira COVID.

Pasina izvi zvinodiwa, kusunungurwa kwechirwere kunoramba kuri nzira yakanakisisa uye ine mutoro kuChina sezvo nyika isingakwanise kuisa hupenyu hwevanhu vakuru panjodzi nekurerutsa matanho ayo ekudzivirira denda nguva isati yakwana, akadaro Wang Guiqiang, mukuru wedhipatimendi rezvirwere zvinotapukira paPeking University First Hospital.

Nyika yeChina yakashuma kuti vanhu 226 vakabatwa neCOVID-19 vakapararira munharaunda neMugovera, 166 vavo vari muShanghai uye 33 vari muBeijing, sekureva kweNational Health Commission neSvondo.

Mumusangano wepachena neMugovera, Wang, uyo ariwo nhengo yechikwata chenyanzvi dzenyika panyaya dzekurapa vanhu vane COVID-19, akati kubuda kweCOVID-19 muHong Kong neShanghai kwaratidza kuti Omicron inogona kutyisidzira vakwegura, kunyanya avo vasina kubaiwa majekiseni uye vane matambudziko ehutano.

"Kana China ichida kuvhurazve, chinodiwa panhamba 1 ndechekuderedza huwandu hwevanhu vanofa nekuda kweCOVID-19, uye nzira yakanakisisa yekuita izvi ndeyekubaiwa majekiseni," akadaro.

Ruzivo rwehutano hwevanhu rweHong Kong Special Administrative Region rwakaratidza kuti kusvika Mugovera, huwandu hwevanhu vakafa nekuda kwedenda reOmicron hwaive 0.77 muzana, asi nhamba yacho yakakwira kusvika pa2.26 muzana kune vasina kubaiwa majekiseni kana avo vasina kupedza kubaiwa majekiseni.

Vanhu vanosvika 9,147 vakafa mudenda rekupedzisira muguta iri kusvika neMugovera, vazhinji vavo vari vakwegura vane makore 60 zvichikwira. Kune avo vane makore anopfuura 80, huwandu hwevakafa hwaive 13.39 muzana kana vasina kuwana kana kupedza majekiseni avo ekudzivirira chirwere.

Kubva neChina, vakwegura vanopfuura mamiriyoni mazana maviri nemakumi maviri nemasere vane makore anopfuura makumi matanhatu (60) vari munyika yeChina vakange vabaiwa nhomba, avo mamiriyoni mazana maviri negumi nematanhatu (216 million) vakange vapedza kubaiwa nhomba yese uye vakwegura vanosvika mamiriyoni zana nemakumi matanhatu nemana (164 million) vakange vabaiwa nhomba yekuwedzera, yakadaro National Health Commission. Nyika yeChina yaive nevanhu vanosvika mamiriyoni mazana maviri nemakumi matanhatu nemana (264 million) vari muboka iri rezera muna Mbudzi 2020.

Dziviriro inokosha

"Kuwedzera huwandu hwemajekiseni ekudzivirira neanopa vanhu vakwegura mukana wekuvadzivirira kubva kuzvirwere zvakakomba nerufu," akadaro Wang.

China yatove kugadzira majekiseni akagadzirirwa mushonga weOmicron unotapuriranwa zvakanyanya. Pakutanga kwemwedzi uno, China National Biotech Group, kambani iri pasi peSinopharm, yakatanga kuyedza mushonga wayo weOmicron muHangzhou, dunhu reZhejiang.

Sezvo dziviriro yekudzivirira chirwere chekoronavirus ichigona kudzikira nekufamba kwenguva, zvingangoita uye zvakakosha kuti vanhu, kusanganisira avo vakambopihwa jekiseni rekuwedzera simba rekudzivirira chirwere, vawedzere simba rekudzivirira chirwere chavo zvakare nejekiseni reOmicron kana rabuda, Wang akawedzera.

Kunze kwekubaiwa nhomba, Wang akati zvakakosha kuva nenzira yakanyatsogadzirwa yekurwisa kupararira kweCOVID-19 kuchengetedza hurongwa hwehutano hwenyika.

Semuenzaniso, panofanira kuva nemitemo yakajeka yekuti vanhu vanofanira kuiswa mudzimba dzavo sei uye kuti sei kuitira kuti vashandi vemunharaunda vagone kutarisira nekubatsira vanhu vakaiswa mudzimba dzavo nemazvo, uye kuitira kuti zvipatara zvisanyanya kukanganiswa nekuwanda kwevarwere vane hutachiona.

"Zvakakosha kuti zvipatara zvigone kupa rubatsiro rwakakosha kune vamwe varwere panguva yekukwira kweCOVID-19. Kana kuvhiyiwa uku kukakanganiswa neboka revarwere vatsva, zvinogona kukonzera kufa zvisina kunanga, izvo zvisingagamuchirwi," akadaro.

Vashandi vemunharaunda vanofanirawo kutevedzera mamiriro evakwegura neavo vane zvinodiwa zvekurapa zvakakosha vari mu quarantine, kuitira kuti vashandi vezvehutano vagone kupa rubatsiro rwekurapa nekukurumidza kana zvichidikanwa, akawedzera.

Pamusoro pezvo, veruzhinji vachada mishonga inorwisa mavhairasi isingadhuri uye iri nyore kushandisa, akadaro Wang. Kurapwa kwe monoclonal antibody kuri kuitwa pari zvino kunoda kubaiwa jekiseni muchipatara, uye piritsi rePfizer reCOVID remuromo rinonzi Paxlovid rine mutengo mukuru we2,300 yuan ($338.7).

"Ndinovimba kuti mishonga yedu yakawanda, pamwe nemishonga yechivanhu yeChina, inogona kuita basa guru mukurwisa denda iri," akadaro. "Kana tikakwanisa kuwana mushonga une simba uye unodhura, tichava nechivimbo chekuvhurazve."

Zvinodiwa zvakakosha

Zvichakadaro, kuvandudza kururama kwemakitsi ekuzviongorora e-antigen nekukurumidza uye kuwedzera mukana wekuwana nekugona kwekuongorora nucleic acid padanho renharaunda zvakare zvinhu zvakakosha kuti pave nekuvhurwazve, akadaro Wang.

"Kazhinji, ino haisi nguva yekuti China ivhurwe patsva. Nekuda kweizvozvo, tinofanira kutsigira hurongwa hwekusunungura varwere nekudzivirira vakwegura vane matambudziko ehutano," akadaro.

Lei Zhenglong, mutevedzeri wemukuru weNational Health Commission's Bureau of Disease Prevention and Control, akadzokorora neChishanu kuti mushure mekurwisa denda reCOVID-19 kwemakore anopfuura maviri, hurongwa hwekusunungura vanhu hwakaratidza kushanda zvakanaka mukuchengetedza hutano hwevanhu, uye ndiyo sarudzo yakanakisa yeChina tichifunga nezvemamiriro aripo iye zvino.